These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10326739)

  • 1. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
    Blahová J; Králiková K; Krcméry V; Schäfer V
    J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
    Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K
    Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.
    Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Mikovicová A
    J Chemother; 1996 Aug; 8(4):266-9. PubMed ID: 8873831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases].
    Babálová M; Blahová J; Králiková K; Krcméry V; Hanzen J; Balogová O; Milosovic P
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):21-7. PubMed ID: 11038673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferable resistance to specific antibiotics in nosocomial strains of Pseudomonas aeruginosa from two teaching hospitals.
    Blahová J; Králiková K; Krcméry V; Schäfer V; Torsová V
    J Chemother; 1996 Dec; 8(6):420-4. PubMed ID: 8981181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
    Babálová M; Krălíková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
    Blahová J; Králiková K; Krcméry V; Torsová V
    Zentralbl Bakteriol; 1997 Nov; 286(4):449-55. PubMed ID: 9440193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further occurrence of extended-spectrum beta-lactamase-producing Salmonella enteritidis.
    Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Krcméryová T; Kubonová K
    J Chemother; 1998 Aug; 10(4):291-4. PubMed ID: 9720467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
    Hupková M; Blahová J; Babálová M; Krcméry V; Králiková K
    J Chemother; 1995 Feb; 7(1):16-20. PubMed ID: 7629551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
    Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
    Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.
    Bonnet R; Dutour C; Sampaio JL; Chanal C; Sirot D; Labia R; De Champs C; Sirot J
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2269-75. PubMed ID: 11451684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.